SSI INVESTMENT MANAGEMENT LLC - ISIS PHARMACEUTICALS INC DEL ownership

Quarter-by-quarter ownership
SSI INVESTMENT MANAGEMENT LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2020$620,000
-7.0%
600,000
-1.0%
0.05%
-8.6%
Q2 2020$667,000
+9.3%
606,0000.0%0.06%
+7.4%
Q1 2020$610,000
-11.8%
606,0000.0%0.05%
+17.4%
Q4 2019$692,000
-92.3%
606,000
-92.3%
0.05%
-93.0%
Q3 2019$8,977,000
-43.5%
7,872,000
-41.4%
0.65%
-44.6%
Q2 2019$15,893,000
-14.5%
13,441,000
-2.2%
1.18%
-24.1%
Q1 2019$18,579,000
+49.9%
13,745,000
+18.7%
1.56%
+34.3%
Q4 2018$12,391,000
+21.2%
11,581,000
+19.0%
1.16%
+47.3%
Q3 2018$10,222,000
+6.8%
9,731,000
-0.1%
0.79%
+0.5%
Q2 2018$9,573,000
-16.5%
9,742,000
-16.1%
0.78%
-15.9%
Q1 2018$11,468,000
+3.3%
11,606,000
+10.4%
0.93%
+0.5%
Q4 2017$11,103,000
+101.5%
10,516,000
+101.5%
0.93%
+97.0%
Q3 2017$5,511,000
+76.6%
5,218,000
+77.2%
0.47%
+70.9%
Q2 2017$3,121,000
+13.3%
2,944,000
+3.0%
0.28%
+8.7%
Q1 2017$2,755,000
-47.4%
2,859,000
-45.1%
0.25%
-47.3%
Q4 2016$5,242,000
+110.9%
5,204,000
+94.8%
0.48%
+118.2%
Q3 2016$2,485,000
-11.0%
2,671,000
-32.4%
0.22%
-17.9%
Q2 2016$2,792,000
-52.6%
3,950,000
-39.0%
0.27%
-55.6%
Q1 2016$5,889,000
+148.2%
6,474,000
+207.0%
0.60%
+148.6%
Q4 2015$2,373,0002,109,0000.24%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q3 2023
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 74,881,000$76,559,0001.97%
III Capital Management 15,000,000$15,227,0001.82%
TFG Asset Management GP Ltd 14,055,000$14,321,0001.02%
MACKAY SHIELDS LLC 28,304,000$28,739,0000.21%
RWC Asset Management LLP 6,500,000$6,604,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 7,187,000$7,281,0000.17%
CQS (US), LLC 4,000,000$4,092,0000.13%
FARALLON CAPITAL MANAGEMENT LLC 24,435,000$24,797,0000.12%
D. E. Shaw & Co., Inc. 59,728,000$60,845,0000.06%
BNP Paribas Asset Management Holding S.A. 7,000,000$7,133,0000.03%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders